Noriyuki Kasahara
Professor · University of California (San Francisco) School of Medicine
Credentials: · · ·
History
Pathology-Anatomic and Clinical
Research
Tissue-specific targeting of retroviral vectors through ligand-receptor interactions
Science · 1994 · First of 3 authors · 370 citations
L1 retrotransposition in nondividing and primary human somatic cells
Proceedings of the National Academy of Sciences of the United States of America · 2006 · Last of 7 authors · 153 citations
Phase 1 trial of vocimagene amiretrorepvec and 5-fluorocytosine for recurrent high-grade glioma
Science Translational Medicine · 2016 · 152 citations
- HG
16 papers
- BB
6 papers
6 papers
5 papers
4 papers
4 papers
- DP
3 papers
- JH
3 papers
Grants
- 2017–2023
Retroviral Replicating Vector-Mediated Gene Therapy for Ovarian Cancer
National Cancer Institute · R01
Contact PI · $2.6M · University of California, San Francisco
- 2019–2022
GALV-Based Retroviral Replicating Vectors for Glioma Gene Therapy
National Institute of Neurological Disorders and Stroke · R33
Contact PI · $403.7K · University of California, San Francisco
- 2004–2021
CURE: Digestive Diseases Research Center
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $1.7M · University of California Los Angeles
- 2019–2021
GALV-Based Retroviral Replicating Vectors for Glioma Gene Therapy
National Institute of Neurological Disorders and Stroke · R21
Contact PI · $798.3K · University of California, San Francisco
Clinical trials
- 2025–2042
DB107-RRV, DB107-FC, and Radiation Therapy With or Without Temozolomide (TMZ) for High Grade Glioma
Principal investigator · Recruiting · Phase 1, Phase 2
University of California, San Francisco